[1]
“Role of Glycemic Control in Modulating Coronary Inflammation and Plaque Vulnerability in Low-Risk ACS: A Coronary CT-Based FAI Study”, VER, vol. 8, no. 9s, pp. 375–382, Nov. 2025, Accessed: Apr. 28, 2026. [Online]. Available: https://verjournal.com/index.php/ver/article/view/770